Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracy.
Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: beatrici v. World J Urol. 2023 Jan;41(1):77-84. doi: 10.1007/s00345-022-04244-4. Epub 2022 Dec 12. World J Urol. 2023. PMID: 36509932
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Among authors: beatrici v. Prostate. 2023 May;83(6):572-579. doi: 10.1002/pros.24490. Epub 2023 Jan 27. Prostate. 2023. PMID: 36705314
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study.
Mjaess G, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S, Diamand R. Mjaess G, et al. Among authors: beatrici v. Eur Urol Focus. 2023 Nov;9(6):992-999. doi: 10.1016/j.euf.2023.04.008. Epub 2023 May 3. Eur Urol Focus. 2023. PMID: 37147167
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?
Diamand R, Albisinni S, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, An Nguyen T, Fournier G, Fiard G, Ploussard G, Peltier A, Roumeguère T. Diamand R, et al. Among authors: beatrici v. Eur Urol Focus. 2023 Mar;9(2):298-302. doi: 10.1016/j.euf.2022.09.011. Epub 2022 Oct 6. Eur Urol Focus. 2023. PMID: 36210296
External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Diamand R, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Favre MM, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Peltier A, Albisinni S. Diamand R, et al. Among authors: beatrici v. Eur Urol Focus. 2023 Mar;9(2):309-316. doi: 10.1016/j.euf.2022.09.006. Epub 2022 Sep 21. Eur Urol Focus. 2023. PMID: 36153227
MRI/US fusion prostate biopsy in men on active surveillance: Our experience.
Lacetera V, Antezza A, Papaveri A, Cappa E, Cervelli B, Gabrielloni G, Montesi M, Morcellini R, Parri G, Recanatini E, Beatrici V. Lacetera V, et al. Among authors: beatrici v. Arch Ital Urol Androl. 2021 Mar 22;93(1):88-91. doi: 10.4081/aiua.2021.1.88. Arch Ital Urol Androl. 2021. PMID: 33754618 Free article.
Elastic fusion biopsy versus systematic biopsy for prostate cancer detection: Results of a multicentric study on 1,119 patients.
Oderda M, Marra G, Albisinni S, Altobelli E, Baco E, Beatrici V, Dellabella M, Descotes JL, Eldred-Evans D, Fasolis G, Ferriero M, Fiard G, Giacobbe A, Kumar P, Lacetera V, Mozer P, Muto G, Papalia R, Peltier A, Piechaud T, Pierangeli T, Simone G, Roche JB, Roupret M, Gontero P. Oderda M, et al. Among authors: beatrici v. Actas Urol Esp (Engl Ed). 2019 Oct;43(8):431-438. doi: 10.1016/j.acuro.2019.01.009. Epub 2019 May 31. Actas Urol Esp (Engl Ed). 2019. PMID: 31155373 English, Spanish.
A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy.
Diamand R, Oderda M, Al Hajj Obeid W, Albisinni S, Van Velthoven R, Fasolis G, Simone G, Ferriero M, Roche JB, Piechaud T, Pastore A, Carbone A, Fiard G, Descotes JL, Marra G, Gontero P, Altobelli E, Papalia R, Kumar P, Eldred-Evans D, Giacobbe A, Muto G, Lacetera V, Beatrici V, Roumeguere T, Peltier A. Diamand R, et al. Among authors: beatrici v. World J Urol. 2019 Oct;37(10):2109-2117. doi: 10.1007/s00345-019-02634-9. Epub 2019 Jan 16. World J Urol. 2019. PMID: 30652213
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patients.
Oderda M, Marra G, Albisinni S, Altobelli E, Baco E, Beatrici V, Cantiani A, Carbone A, Ciccariello M, Descotes JL, Dubreuil-Chambardel M, Eldred-Evans D, Fasolis G, Ferriero M, Fiard G, Forte V, Giacobbe A, Kumar P, Lacetera V, Mozer P, Muto G, Papalia R, Pastore A, Peltier A, Piechaud T, Simone G, Roche JB, Roupret M, Rouviere O, Van Velthoven R, Gontero P. Oderda M, et al. Among authors: beatrici v. Int J Urol. 2018 Dec;25(12):990-997. doi: 10.1111/iju.13796. Epub 2018 Sep 5. Int J Urol. 2018. PMID: 30187529
17 results